These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13069321)

  • 1. A new inactivating medium for hexachlorophene (G-11).
    LAWRENCE CA; ERLANDSON AL
    J Am Pharm Assoc Am Pharm Assoc; 1953 Jun; 42(6):352-7. PubMed ID: 13069321
    [No Abstract]   [Full Text] [Related]  

  • 2. The adsorption of dodecylbenzenesulfonate and hexachlorophene on the skin.
    COMPEAU GM
    J Am Pharm Assoc Am Pharm Assoc; 1960 Sep; 49():574-80. PubMed ID: 14448753
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivating medium for hexachlorophene (G11) types of compounds and some substituted phenolic disinfectants.
    ERLANDSON AL; LAWRENCE CA
    Science; 1953 Sep; 118(3062):274-6. PubMed ID: 13089672
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non-ionic surface-active agents as neutralizing media for the evaluation of the bactericidal properties of hexachlorophene].
    Kariukhina VS; Gel'fer TsM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Dec; 50(12):50-4. PubMed ID: 4594661
    [No Abstract]   [Full Text] [Related]  

  • 5. Interference by surface-active agents with the 4-aminoantipyrine determination of hexachlorophene and other phenols.
    Brown KF; Guttman DE; Anderson AS
    J Pharm Sci; 1969 Nov; 58(11):1393-8. PubMed ID: 5349757
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the decrease of antiseptic activity which 4,4'-diamidino-1,6-diphenoxyhexane diisethionate, isopropanolamine lauryl sulfate and hexachlorophene undergo following contact with the human skin or with blood].
    DELMOTTE A; CAUCHETEUR G
    Therapie; 1962; 17():53-62. PubMed ID: 13885227
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival of gram-negative bacteria on plastic compounded with hexachlorophene.
    Taylor GF
    Appl Microbiol; 1970 Jan; 19(1):131-3. PubMed ID: 5415208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Staphylococcus aureus by combinations of non-ionic surface active agents and antibacterial substances.
    Allwood MC
    Microbios; 1973; 7(28):209-14. PubMed ID: 4750937
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of nonionic and ampholytic surface-active agents on the bactericidal activity of hexachlorophene, glutaraldehyde and chlorhexidine].
    Cremieux A; Guiraud-Dauriac H; Bendjelloul D
    J Pharm Belg; 1983; 38(1):22-6. PubMed ID: 6408238
    [No Abstract]   [Full Text] [Related]  

  • 10. A BACTERIOSTATIC EMOLLIENT: ITS USE AS A CLEANSER AND BATH ADDITIVE.
    REISCH M; MARCIANO MR
    Ind Med Surg; 1963 Oct; 32():430-4. PubMed ID: 14068913
    [No Abstract]   [Full Text] [Related]  

  • 11. Mastitis prophylaxis. A comparative study of udder wash with sodium hypochlorite, iodophor and hexachlorophene.
    Hansen SR
    Acta Vet Scand; 1971; 12(1):80-5. PubMed ID: 5103413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Solubilization and emulgation of hexachlorophene].
    Minkov E; Zahariewa M; Botev B; Popov A; Trandafilov T
    Pharmazie; 1970; 25(5):353-6. PubMed ID: 5455420
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of cerebroprotective substances in the management of functional disorders induced by the cytotoxic brain oedema-producing substance hexachlorophene.
    Andreas K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):79-83. PubMed ID: 8446185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexachlorophane teratogenicity in rats.
    Kimmel CA; Moore W; Stara JF
    Lancet; 1972 Dec; 2(7789):1251. PubMed ID: 4117739
    [No Abstract]   [Full Text] [Related]  

  • 15. Degerming the cutaneous surface. II. Hexachlorophene (G-11).
    BLANK IH; COOLIDGE MH
    J Invest Dermatol; 1950 Sep; 15(3):257-63. PubMed ID: 14774587
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of solubilisation on the antibacterial activity of hexachlorophane.
    Anderson RA; Morgan KJ
    J Pharm Pharmacol; 1966 Jul; 18(7):449-56. PubMed ID: 4381727
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro studies of mixtures of antibacterial substances. 4. Bacteriostatic effect of the mixtures D-47-hexachlorophene, D-47-Raschit-condensate and hexachlorophene-Raschit-condensate].
    Weuffen W; Popp H; Jülich WD
    Z Gesamte Hyg; 1967 Nov; 13(11):866-9. PubMed ID: 5618474
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and laboratory evaluation of G-11 (hexachlorophene) as a preoperative skin bacteriostatic agent.
    KRAISSL CJ
    Plast Reconstr Surg (1946); 1950 Jun; 5(6):471-85. PubMed ID: 15430159
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell binding and growth inhibition by hexachlorophene of decanoate and their reversibility.
    Levin BC; Freese E
    J Environ Sci Health C; 1978; 13(1):1-31. PubMed ID: 96167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of benzoyl peroxide and hexachlorophene. In vivo studies against propionibacterium acnes in humans.
    Nacht S; Gans EH; McGinley KJ; Kligman AM
    Arch Dermatol; 1983 Jul; 119(7):577-9. PubMed ID: 6222704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.